<?xml version="1.0" encoding="UTF-8"?>
<p id="p0145">In April 2020, several severely unwell children with fever and shock were described in the United Kingdom (UK) in association with SARS-CoV-2 infection.
 <xref rid="bib108" ref-type="bibr">
  <sup>108</sup>
 </xref> No such cases had been reported prior to this from China, and a solitary case from the US of Kawasaki disease (KD) with concurrent detection of SARS-CoV-2 infection had been published.
 <xref rid="bib109" ref-type="bibr">
  <sup>109</sup>
 </xref> Further cases were later identified in the UK and the condition was labelled ‘paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2’ (PIMS-TS).
 <xref rid="bib108" ref-type="bibr">
  <sup>108</sup>
 </xref> Reports subsequently emerged from other high-burden settings regarding children with fever, shock, rash and abdominal pain, some of whom met diagnostic criteria for KD;
 <xref rid="bib110" ref-type="bibr">110</xref>, 
 <xref rid="bib111" ref-type="bibr">111</xref>, 
 <xref rid="bib112" ref-type="bibr">112</xref>, 
 <xref rid="bib113" ref-type="bibr">113</xref> many of these children were seropositive for prior SARS-CoV-2 infection and a minority showed concurrent detection of SARS-CoV-2 via RT-PCR.
 <xref rid="bib108" ref-type="bibr">
  <sup>108</sup>
 </xref>
 <sup>,</sup>
 <xref rid="bib110" ref-type="bibr">
  <sup>110</sup>
 </xref>
 <sup>,</sup>
 <xref rid="bib111" ref-type="bibr">
  <sup>111</sup>
 </xref> The US Centers for Disease Control and Prevention (CDC) has named the syndrome ‘multisystem inflammatory syndrome in children associated with COVID-19’ (MIS-C).
 <xref rid="bib114" ref-type="bibr">
  <sup>114</sup>
 </xref>
</p>
